Abraham Bassan

Abe Bassan is a Vice President at Samsara BioCapital. Prior to Samsara, Abe was Director of Program Biology at Revolution Medicines, where he co-led the company’s 4EBP1/mTORC1 cancer program through early preclinical development. Prior to that, Abe was at bluebird bio (BLUE), where he drove project management for gene therapy programs focused on β-Thalassemia, Sickle Cell Anemia, and Childhood Cerebral ALD. Before joining bluebird, Abe was an Associate at Third Rock Ventures, where he focused on technical diligence for the firm’s investment in bluebird bio, and played a central role in developing the company concept for Blueprint Medicines (BPMC), a precision medicine oncology company. Abe was also the founder of Aurora Medical, which focused on international commercialization of molecular diagnostics testing services. Abe received an AB in Molecular Biology from Princeton University, and an MS in Developmental Biology from Stanford University.